<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In addition to presenting clinicopathological findings in 3 patients with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> developed in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, we have investigated the expression of cell cycle-related factors, oncogenes and cell proliferation in <z:mpath ids='MPATH_458'>normal</z:mpath> squamous epithelium, specialized columnar epithelium (SCE) and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, using immunohistological techniques </plain></SENT>
<SENT sid="1" pm="."><plain>The expression of p21 in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> tended to be decreased in two mutated p53-strongly-positive patients and to be increased in one mutated p53-weakly-positive patient </plain></SENT>
<SENT sid="2" pm="."><plain>Furthermore, mutated p53 was strongly expressed in the deep layer of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, while p21 was expressed in the superficial layer of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, mutated p53 was inversely correlated with p21 in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The mean positive cell rate (PR) of Ki-67 was 4% in <z:mpath ids='MPATH_458'>normal</z:mpath> squamous epithelium, 24.5% in the SCE, and 41.7% in the <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The mean PR of proliferating cell nuclear antigen (PCNA) was 6% in <z:mpath ids='MPATH_458'>normal</z:mpath> squamous epithelium, 29.5% in the SCE, and 55% in the <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, the PR of Ki-67 and PCNA were clearly higher in the SCE in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> than in <z:mpath ids='MPATH_458'>normal</z:mpath> squamous epithelium, indicating <z:mp ids='MP_0000351'>increased cell proliferation</z:mp> in the SCE in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, mutated p53 was inversely correlated with p21 in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>p53 mutation and the expression of oncogenes such as c-erbB-2 and MDM2 were observed in the SCE in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, which showed higher cell proliferation than <z:mpath ids='MPATH_458'>normal</z:mpath> squamous epithelium, suggesting a high malignant potential of the SCE in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>We considered that it was important to carefully follow-up patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
</text></document>